Your browser doesn't support javascript.
loading
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis.
Aqel, Bashar A; Pungpapong, Surakit; Leise, Michael; Werner, K Tuesday; Chervenak, Amy E; Watt, Kymberly D; Murphy, Jennifer L; Ryland, Kristen; Keaveny, Andrew P; McLemore, Ryan; Vargas, Hugo E.
Afiliação
  • Aqel BA; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
  • Pungpapong S; Department of Transplant, Mayo Clinic, Jacksonville, FL.
  • Leise M; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Werner KT; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
  • Chervenak AE; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
  • Watt KD; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Murphy JL; Department of Transplant, Mayo Clinic, Jacksonville, FL.
  • Ryland K; Department of Transplant, Mayo Clinic, Jacksonville, FL.
  • Keaveny AP; Department of Transplant, Mayo Clinic, Jacksonville, FL.
  • McLemore R; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
  • Vargas HE; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
Hepatology ; 62(4): 1004-12, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26096332

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Hepatite C / Simeprevir / Sofosbuvir Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Hepatite C / Simeprevir / Sofosbuvir Idioma: En Ano de publicação: 2015 Tipo de documento: Article